Search

Your search keyword '"Crettol, Séverine"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Crettol, Séverine" Remove constraint Author: "Crettol, Séverine"
40 results on '"Crettol, Séverine"'

Search Results

1. Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studies

3. Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients

4. Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients

5. Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort

8. Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort

9. Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity

13. Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances

16. Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study

19. Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study

20. Pharmacogenetic studies on methadone and immunosuppressive drugs

22. Multicenter Study on the Clinical Effectiveness, Pharmacokinetics, and Pharmacogenetics of Mirtazapine in Depression

23. ABCB1 and Cytochrome P450 Polymorphisms

29. ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment*.

31. CYP3A7, CYP3A5, CYP3A4, and ABCB1Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant Recipients

33. Increased (R)-Methadone Plasma Concentrations by Quetiapine in Cytochrome P450s and ABCB1Genotyped Patients

34. Increased Clozapine Plasma Concentrations and Side Effects Induced by Smoking Cessation in 2 CYP1A2Genotyped Patients

35. Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study

36. Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?

39. Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.

40. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.

Catalog

Books, media, physical & digital resources